Acinetobacter lwoffii is found in about 25 per cent of healthy people in the nose and throat and skin, however has been implicated in pathogenic infections.
Acinetobacter lwoffii can survive a variety of temperatures and an acidic pH (such as in the urinary tract), and is an emerging opportunistic human pathogen. This means it could show up anywhere.
| Condition type | Bacteria |
|---|---|
| Affected systems | Reproductive |
| Sexually Transmissible | |
| Genitourinary Incidence | rare |
| Age group affected |
Microbial information
| Anaerobe / Aerobe | Aerobe |
|---|---|
| Gram stain | Gram-negative |
| Best tests to detect | |
| Pathogen of |
| Commensal of (Can naturally inhabit, but not necessarily as a healthy addition) |
|
| Optimal growth pH | |
| Conditions correlated with |
|
| Cellular adherence capacities | |
| Found in healthy vaginas | Possibly |
| Biofilm-forming capacities | |
| Cellular Morphology |
|
| Microbe Motility | |
| Colony Colour | |
| Substances Produced | |
| Sexually Transmissible | Possibly |
What are the symptoms of Acinetobacter lwoffii urinary tract and vulvovaginal infections?
What causes Acinetobacter lwoffii urinary tract and vulvovaginal infections?
- No causes found for Acinetobacter lwoffii urinary tract and vulvovaginal infections, yet.
What are the risk factors associated with Acinetobacter lwoffii urinary tract and vulvovaginal infections?
How do you diagnose Acinetobacter lwoffii urinary tract and vulvovaginal infections?
- No diagnoses found for Acinetobacter lwoffii urinary tract and vulvovaginal infections, yet.
How do you treat Acinetobacter lwoffii urinary tract and vulvovaginal infections?
Treatments for Acinetobacter lwoffii urinary tract and vulvovaginal infections are only for practitioners and people who purchased the book Killing BV and Killing BV for men.
Which treatments are likely to be ineffective for Acinetobacter lwoffii urinary tract and vulvovaginal infections?
What complications are associated with Acinetobacter lwoffii urinary tract and vulvovaginal infections?
- No complications found for Acinetobacter lwoffii urinary tract and vulvovaginal infections, yet.
References
Babapour, E. et al., 2016. Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance. Asian Pacific Journal of Tropical Biomedicine, 6(6), pp.528–533, https://www.sciencedirect.com/science/article/pii/S2221169116302957Rossana Rosa, John Mills, L. Silvia Munoz-Price. 2015. Clinical and Microbiological Characteristics of Acinetobacter lwoffii Bacteremia Compared With Acinetobacter Baumannii Open Forum Infectious Diseases, Volume 2, Issue suppl_1, 1 December 2015, 1780 https://doi.org/10.1093/ofid/ofv133.1330